Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

2.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.3K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

800
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
800
Drug Therapy01:28

Drug Therapy

449
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
449
Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: A Comprehensive Review of Novel FDA-Approved Psychiatric Medications (2018-2022).

Cureus·2025
Same author

A Comprehensive Review of Novel FDA-Approved Psychiatric Medications (2018-2022).

Cureus·2024
Same journal

GENETIC AND EPIGENETIC CAUSES OF OBESITY.

Adolescent medicine: state of the art reviews·2018
Same journal

Treating Youth Violence in Hospital and Emergency Department Settings.

Adolescent medicine: state of the art reviews·2018
Same journal

Building an Evidence-Based Multi-Tiered System of Supports for Violence Prevention in the Health Care Setting.

Adolescent medicine: state of the art reviews·2018
Same journal

Addressing Firearm Violence in the Primary Health Care Setting.

Adolescent medicine: state of the art reviews·2018
Same journal

Promoting Resilience in Youth Who Are Violence-Involved.

Adolescent medicine: state of the art reviews·2018
Same journal

Substance Use and Violence: Co-Occurrence and Strategies for Intervention.

Adolescent medicine: state of the art reviews·2018
See all related articles

Related Experiment Video

Updated: May 5, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

744

Impulsivity, irritability, and depression: antidepressants.

David J Mullen1, Jonathan Terry

  • 1Children's Psychiatric Center Inpatient Services, University of New Mexico School of Medicine, Albuquerque, NM, USA. dmullen@salud.unm.edu

Adolescent Medicine: State of the Art Reviews
|December 5, 2013
PubMed
Summary
This summary is machine-generated.

This study clarifies impulsivity, irritability, and depression symptoms, exploring their neurobiology and psychopharmacologic treatments. It provides clinical examples and details on common medications for these conditions.

More Related Videos

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
09:12

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats

Published on: March 17, 2019

9.6K
A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.6K

Related Experiment Videos

Last Updated: May 5, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

744
Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
09:12

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats

Published on: March 17, 2019

9.6K
A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.6K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Impulsivity, irritability, and depression are complex symptoms with overlapping features.
  • Understanding the neurobiological underpinnings is crucial for effective treatment.
  • Current treatment strategies require clear conceptual frameworks.

Purpose of the Study:

  • To define and differentiate the concepts of impulsivity, irritability, and depression.
  • To review the neurobiology associated with each symptom.
  • To explore psychopharmacologic approaches for managing these symptoms.

Main Methods:

  • Literature review of definitional and conceptual issues.
  • Overview of neurobiological mechanisms.
  • Exploration of general psychopharmacologic strategies.
  • Presentation of clinical vignettes and agent-specific information.

Main Results:

  • Conceptual clarity is essential for accurate diagnosis and treatment.
  • Neurobiological pathways offer targets for pharmacologic intervention.
  • Various psychopharmacologic agents can be employed to manage these symptoms.

Conclusions:

  • Effective management of impulsivity, irritability, and depression requires a nuanced understanding of their definitions and neurobiology.
  • Psychopharmacology offers viable treatment options, supported by clinical evidence and specific drug information.